Evonik appoints Yann d’Hervé as new head of Health Care business line
Yann d’Hervé will take over responsibility for the Health Care business at Evonik, effective July 1.
Yann d’Hervé, previously Head of the Care Solutions business line in Evonik’s Nutrition & Care division, will lead the Health Care business line as of July 1.
Yann d’Hervé holds an MSc in Chemistry and an MBA. He joined the former REXIM SAS (France) in 1996, where he worked in a number of different roles. REXIM is now part of the Health Care business line. In 2004, he moved to the U.S. to join what is today’s Oil Additives business line, working as a business analyst and subsequently as Global Business Director for Wax Modifiers. In 2011, the Health Care business line was formed and d’Hervé became Vice President, Sales & Services Americas. In 2015, he assumed the role as Vice President, Global Sales & Services before moving to Germany to lead the Care Solutions business line in 2020.
Yann has extensive experience in manufacturing, finance, marketing, application technology, sales and general management. He has managed international organizations, while being responsible for strategic alliances with key partners. Customer satisfaction and joint value creation are two cornerstones in d’Hervé’s approach to business.
Evonik Health Care partners with the world’s pharmaceutical, medical and nutritional companies to transform complexity into value. With a broad and versatile portfolio of high-quality ingredients, delivery systems and contract services, Evonik Health Care generates distinctive outcomes that advance health and well-being.
Company information
Evonik is one of the world leaders in specialty chemicals. The company is active in more than 100 countries around the world and generated sales of €18.5 billion and an operating profit (adjusted EBITDA) of €2.49 billion in 2022. Evonik goes far beyond chemistry to create innovative, profitable, and sustainable solutions for customers. About 34,000 employees work together for a common purpose: We want to improve life today and tomorrow.
About Nutrition & Care
The focus of the business of the Nutrition & Care division is on health and quality of life. It develops differentiated solutions for active pharmaceutical ingredients, medical devices, nutrition for humans and animals, personal care, cosmetics, and household cleaning. In these resilient end markets, the division generated sales of €4.24 billion in 2022 with about 5,700 employees.
Disclaimer
In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.
